NuVasive, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against NuVasive, Inc. and Its Board of Directors and Deadline of October 28, 2013 to Seek Lead Plaintiff Position -- NUVA

NEW YORK, Oct. 7, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of California on behalf of investors who purchased NuVasive, Inc. ("NuVasive" or the "Company") NUVA common stock between October 22, 2008 and July 30, 2013.

For more information, click here: http://zlk.9nl.com/nuvasive-nuva/.

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (a) the Company submitted false claims to Medicare and Medicaid in violation of federal and state laws and regulations; (b) the Company's internal compliance program was unable to detect and report False Claims Act and other violations; and (c) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times.

On July 30, 2013, the Company disclosed in an SEC filing that it had received a subpoena from the U.S. Department of Health and Human Services in regards to an investigation into possible false or otherwise improper claims submitted to Medicare and Medicaid. The following business day shares of NuVasive declined more than 12% to close at $22.82 per share.

If you suffered a loss in NuVasive you have until October 28, 2013 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/nuvasive-nuva/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.